[Cryoablation for the treatment of persistent or symptomatic paroxysmal atrial fibrillation]

Hernández-Vásquez A, Alcaraz A, Pichon-Riviere A, Augustovski F, García Martí S, Bardach A, Ciapponi A, López A, Rey-Ares L
Record ID 32017000282
Authors' recommendations: No evidence was found on cryoablation-related mortality. Moderate quality evidence showed that cryoablation procedures have a lower rate of short-term and mid-term recurrence than radiofrequency ablation in patients with persistent paroxysmal atrial fibrillation, although they have a higher rate of complications including cerebrovascular disease, cardiac tamponade, bleeding, and phrenic nerve lesions. Moderate quality evidence suggests that cryoablation procedures would be shorter than radiofrequency procedures. The main clinical practice guidelines and coverage policies assessed, consider cryoablation as another treatment alternative, although radiofrequency ablation continues being the standard of care for patients with persistent or symptomatic paroxysmal atrial fibrillation.
Project Status: Completed
Year Published: 2017
URL for published report: www.iecs.org.ar/home-ets/
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Argentina
MeSH Terms
  • Atrial Fibrillation
  • Catheter Ablation
  • Cryosurgery
  • Humans
Organisation Name: Institute for Clinical Effectiveness and Health Policy
Contact Address: Dr. Emilio Ravignani 2024, Buenos Aires - Argentina, C1414 CABA
Contact Name: info@iecs.org.ar
Contact Email: info@iecs.org.ar
Copyright: Institute for Clinical Effectiveness and Health Policy (IECS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.